FAKTOR-OPTIONSSCHEIN - INSPIRE MEDICAL SYSTEMS Stock

Certificat

DE000MG346H1

Real-time Bid/Ask 07:22:56 2024-06-03 EDT
11.73 EUR / 13.93 EUR -18.28% Intraday chart for FAKTOR-OPTIONSSCHEIN - INSPIRE MEDICAL SYSTEMS
1 month+165.65%
Date Price Change
24-06-03 11.78 -24.97%
24-05-31 15.7 +25.40%
24-05-30 12.52 -11.27%
24-05-29 14.11 +13.52%
24-05-28 12.43 +0.24%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 06:46 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INSPIRE MEDICAL SYSTEMS, INC.
Issuer Morgan Stanley
WKN MG346H
ISINDE000MG346H1
Date issued 2024-04-26
Strike 178.7 $
Maturity Unlimited
Parity 1.5 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 23.16
Lowest since issue 3.91
Spread 2.2
Spread %15.87%

Company Profile

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
Sector
-
More about the company

Ratings for Inspire Medical Systems, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Inspire Medical Systems, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
158.8 USD
Average target price
250.7 USD
Spread / Average Target
+57.90%
Consensus